shire map
Select a
Location

Shire Global

Investor Relations

Financial Highlights

Financial Highlights

Total revenue
$billions

$6.4bn

Non GAAP EBITDA1
$billions

$2.9bn

Non GAAP adjusted ROIC2
%

10.3%

Product sales

+5%

$6.1bn

Non GAAP cash generation3

+1%

$2.4bn

People

+11%

5548

Non GAAP EBITDA margin4

-1pps5

43%

Countries medicines available

+6%

72

Non GAAP operating income6

+7%

$2.8bn

1 This is a Non GAAP financial measure. The most directly comparable measure under US GAAP is Net Income (FY 2015; $1,303m, FY 2014: $3,406m).

2 This is a Non GAAP financial measure.

3 This is a Non GAAP financial measure. The most directly comparable measure under US GAAP is Net Cash provided by operating activities (FY 2015: $2,337m, FY 2014: $4,228m).

4 This is a Non GAAP financial measure. The most directly comparable measure under US GAAP is Net Income margin (FY 2015: 20%, FY 2014: 57%).

5 Percentage point change (“pps”).

6 This is a Non GAAP financial measure. The most directly comparable measure under US GAAP is Operating Income (FY 2015: $1,420m, FY 2014: $1,698m).

For a reconciliation of Non GAAP financial measures to the most directly comparable measure under US GAAP, see pages 159 to 163.

By following this link you will be leaving a Shire controlled website for a third party website. Please note that Shire is not responsible or liable for any third party website and the website may not be appropriate for all audiences.

By following this link you will be leaving the global Shire.com website for another Shire website. Please note that this website may not be appropriate for all audiences.

RETURN CONTINUE